Company Filing History:
Years Active: 2021-2022
Title: **Innovations by Sahar R El Hadad: Pioneering Targeted Delivery Systems for Cancer Treatment**
Introduction
Sahar R El Hadad is an accomplished inventor based in Jeddah, Saudi Arabia, known for his innovative contributions to the field of pharmaceuticals. With a total of two patents to his name, his work focuses on advancing targeted drug delivery systems, particularly for the treatment of colorectal cancers.
Latest Patents
One of Sahar's latest patents is centered around the oral administration of 5-fluorouracil (5-FU) in a gelling nanosuspension aimed at targeted delivery for colorectal cancer treatment. This sustained-release formulation utilizes a polymeric coating in a nanosuspension that incorporates sodium alginate and carrageenan. Importantly, the nanosuspension forms an insoluble sedimenting gel in the low pH environment of the stomach, which accelerates gastric emptying. When the gel reaches the small intestine, it becomes soluble in that pH environment, facilitating transport to the colon where 5-FU is released at a predictable rate. This innovative approach effectively inhibits the loss of 5-FU in the gastrointestinal tract, thereby increasing the drug's exposure to cancerous cells in the colon.
Career Highlights
Currently, Sahar R El Hadad is affiliated with King Abdulaziz University, where his research and inventions contribute significantly to the academic and scientific community. His focus on innovative pharmaceutical formulations has marked him as a key figure in the advancement of cancer therapeutics.
Collaborations
Sahar often collaborates with talented colleagues such as Alia M Aldahlawi and Samaa T Abdullah, working jointly on various projects that strive to enhance the efficacy of cancer treatments. These collaborations underscore the importance of teamwork in the pursuit of groundbreaking innovations in medicine.
Conclusion
Sahar R El Hadad's work exemplifies the spirit of innovation and commitment to improving patient outcomes through advanced drug delivery systems. His patented formulations not only highlight his expertise as an inventor but also reflect his dedication to transforming cancer treatment for better therapeutic results. As he continues to work at King Abdulaziz University, his contributions are sure to impact the future of pharmaceutical sciences.